Actively Recruiting
Application of tDCS Stimulation in Controlling Refractory Status Epilepticus
Led by Xuanwu Hospital, Beijing · Updated on 2024-07-31
32
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the study is to assess the efficacy and safety of targeting tDCS stimulation for treatment of Refractory status epilepticus
CONDITIONS
Official Title
Application of tDCS Stimulation in Controlling Refractory Status Epilepticus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 14 and 80 years
- Gender unlimited
- Suitable for EEG monitoring
- Clinical diagnosis of refractory status epilepticus not controlled by two antiepileptic drugs and at least one anesthetic
- Informed consent obtained from participant or surrogate
You will not qualify if you...
- Unstable vital signs (systolic blood pressure less than 90 mmHg, heart rate less than 60 beats per minute, oxygen saturation less than 90%)
- Severe skull injury or defect or medical equipment implanted in the head
- Pregnancy
- Presence of implantable electronic devices (such as pacemakers, vagus nerve stimulators) or metal implants
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100053
Actively Recruiting
Research Team
R
research centre of Xuanwu hospital Capital Medical University
CONTACT
J
Jiaqing Tian, Dr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here